Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.07
+0.43 (0.90%)
At close: Jun 26, 2026, 4:00 PM EDT
48.01
-0.06 (-0.12%)
After-hours: Jun 26, 2026, 7:59 PM EDT

Novo Nordisk Revenue by Segment
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
197.00B 207.11B 214.33B 213.12B 211.73B 206.62B 198.11B 192.75B
Diabetes Growth
-6.96% 0.24% 8.19% 10.57% 16.05% 19.11% 22.93% 24.59%
Obesity
84.84B 82.35B 81.31B 79.00B 72.54B 65.15B 54.97B 48.42B
Obesity Growth
16.96% 26.40% 47.92% 63.15% 61.82% 56.48% 53.16% 73.14%
Rare Disease
19.20B 19.61B 19.96B 19.82B 18.87B 18.64B 17.51B 16.83B
Rare Disease Growth
1.75% 5.20% 14.05% 17.73% 11.21% 8.60% 0.34% -9.75%

Operating Income by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
126.46B 131.44B 140.70B 134.75B 127.72B 117.71B 110.96B 106.68B
Diabetes and Obesity Care Growth
-0.99% 11.67% 26.80% 26.31% 28.20% 29.95% 35.29% 41.90%
Rare Disease
1.21B 1.22B 2.10B 536.00M 620.00M 661.00M 504.00M 2.74B
Rare Disease Growth
95.48% 83.81% 317.46% -80.40% -78.99% -71.50% -87.86% -50.18%

Revenue by Geography
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
164.24B 173.17B 183.79B 185.24B 183.21B 178.17B 165.43B 157.88B
North America Growth
-10.36% -2.81% 11.10% 17.33% 24.96% 30.41% 37.09% 44.35%
International
136.81B 135.90B 131.82B 126.70B 119.93B 112.23B 105.15B 100.12B
International Growth
14.07% 21.09% 25.36% 26.54% 22.84% 17.36% 12.08% 8.89%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.